![Gerd Auffarth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerd Auffarth
Directeur/Bestuurslid bij
OUTLOOK THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2026
Profiel
Gerd U.
Auffarth is currently Chief Executive Officer at Steinbeis-transferzentrum.
Since 2011, the Chairman of the Ophthalmology Department at Ruprecht-Karls-Universität Heidelberg.
Director at The European Society of Cataract & Refractive Surgeons since 2005.
Independent Director at Outlook Therapeutics, Inc. since 2020.
Director at International Vision Correction Research Centre since 2006.
Director at David J Apple International Laboratory For Ocular Pathology since 2012.
Director at German Ophthalmological Society since 2012.
President at Deutschsprachige Gesellschaft Fur Intraokularlinsen since 2012.
Former Independent Director at Presbia PLC.
Education includes doctorates from RWTH Aachen University (1990) and Ruprecht-Karls-Universität Heidelberg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Gerd Auffarth
| Bedrijven | Functie | Begin |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | 20-04-2020 |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-04-2011 |
International Vision Correction Research Centre | Directeur/Bestuurslid | 01-08-2006 |
The European Society of Cataract & Refractive Surgeons
 The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Directeur/Bestuurslid | 01-09-2005 |
David J Apple International Laboratory For Ocular Pathology | Directeur/Bestuurslid | 01-06-2012 |
German Ophthalmological Society | Directeur/Bestuurslid | 01-09-2012 |
Steinbeis-transferzentrum | Algemeen Directeur | - |
Deutschsprachige Gesellschaft Fur Intraokularlinsen | President | 01-03-2012 |
Eerdere bekende functies van Gerd Auffarth
| Bedrijven | Functie | Einde |
|---|---|---|
| PRESBIA PLC | Directeur/Bestuurslid | - |
Opleiding van Gerd Auffarth
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Society of Cataract & Refractive Surgeons
The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Commercial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Steinbeis-transferzentrum | |
Presbia PLC
 Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
International Vision Correction Research Centre | |
David J Apple International Laboratory For Ocular Pathology | |
German Ophthalmological Society | |
Deutschsprachige Gesellschaft Fur Intraokularlinsen |
